Cell Therapy
Total Trials
13
As Lead Sponsor
As Collaborator
0
Total Enrollment
6,866
NCT01216280
Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2010
Completion: Sep 30, 2011
NCT03366207
Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
Phase: Phase 4
Start: Dec 15, 2017
Completion: Oct 26, 2018
NCT03354598
Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women
Phase: Phase 3
Start: Aug 1, 2018
Completion: Jan 20, 2020
NCT03357614
Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
Start: Sep 18, 2018
Completion: Dec 14, 2019
NCT03358576
Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
Completion: Oct 2, 2019
NCT04421391
QuadraMune(TM) for Prevention of COVID-19
Phase: N/A
Start: Jun 8, 2020
Completion: Nov 8, 2020
NCT04606875
Correlation of Campbell Score With Suicidal Ideation
Start: Nov 5, 2020
Completion: Feb 13, 2021
NCT04648007
Validation of Kaihani Score for Gambling Addiction
Start: Dec 15, 2020
Completion: Mar 30, 2021
NCT05026801
Azithromycin Plus Hydroxychloroquine for COVID-19 Infection
Start: Feb 8, 2021
Completion: Aug 26, 2021
NCT04700787
Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents
Phase: Phase 1
Start: Apr 30, 2021
Completion: Apr 4, 2022
NCT05584657
Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women
Start: Oct 18, 2022
Completion: Nov 21, 2023
NCT07092813
Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents
Start: Sep 30, 2025
Completion: Jul 31, 2026
Loading map...